Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile
Raphael Twerenbold, MD

@rtwerenbold

Full-Professor of Cardiology | Interventional Cardiologist | Clinical Researcher | Enthusiast of Cardiovascular Biomarkers and Genomics | Medtech entrepreneur

ID: 828303545766146050

linkhttps://www.uke.de/english/departments-institutes/centers/university-heart-center/index.html calendar_today05-02-2017 18:05:29

212 Tweet

501 Followers

160 Following

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

New RCT on the utility of non-sensitive POC troponin testing in the pre-hospital triage of MI, suggesting high-safety in very low-risk patients. ❤️‍🩹🚑 Impact and applicability is expected to be even greater when using high-sensitivity POC tests.

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Proud to see Jonas Lehmacher from University Center of Cardiovascular Science (UCCS) presenting data on the additive prognostic utility of biomarkers beyond traditional risk factors in the young investigator award session. #DGKJahrestagung

Proud to see <a href="/JonasLehmacher/">Jonas Lehmacher</a> from <a href="/UCCS_HH/">University Center of Cardiovascular Science (UCCS)</a> presenting data on the additive prognostic utility of biomarkers beyond traditional risk factors in the young investigator award session.  #DGKJahrestagung
Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Very pleased with today‘s election of our medical director Stefan Blankenberg from the UHZ UKE Hamburg as the next president of the German Society of Cardiology.🫀 🎉👏🏻

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Congrats María Rubini ! 🫀👏🏻 Proud to see your story of success. Putting young professionals at the heart of the cardiovascular community: Maria Rubini Gimenez, MD academic.oup.com/eurheartj/arti… María Rubini

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

🚨 Just published: a machine-learning approach to safely identify or exclude MI more efficiently, flexibly and individually than current standard of care. ❤️‍🩹? =👩🏼‍⚕️🩺🧪📲 = 🆘 or ✅. Thanks to the whole research consortium.

HamburgBeats (@hamburgbeats) 's Twitter Profile Photo

Runde 1 im Boxring 🥊 bei den HamburgBeats Blaue Ecke: Christian Veltmann Rote Ecke: Christina Magnussen Gefightet wird um's Thema: "Herzinsuffizienz bei Vorhofflimmern mit Tachymyopathie: Klar kann ich die Herzinsuffizienz-Medikation wieder absetzen, wenn die EF normal ist!"

Runde 1 im Boxring 🥊 bei den <a href="/HamburgBeats/">HamburgBeats</a>

Blaue Ecke: Christian Veltmann
Rote Ecke: Christina Magnussen

Gefightet wird um's Thema: "Herzinsuffizienz bei Vorhofflimmern mit Tachymyopathie: Klar kann ich die Herzinsuffizienz-Medikation wieder absetzen, wenn die EF normal ist!"
EHJ Editor-in-Chief (@ehj_ed) 's Twitter Profile Photo

Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice. #EHJ academic.oup.com/eurheartj/adva… #HF #diuretics #therapy #acetazolamide #SGLT2i #cardiotwitter European Society of Cardiology European Society of Cardiology Journals

Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice. #EHJ
academic.oup.com/eurheartj/adva…

#HF #diuretics #therapy #acetazolamide #SGLT2i #cardiotwitter <a href="/escardio/">European Society of Cardiology</a> <a href="/ESC_Journals/">European Society of Cardiology Journals</a>
Jeanette Erdmann (@jeanetteerdmann) 's Twitter Profile Photo

Jetzt online: Abenteuer Diagnose #59 "Die Forscherin und das Geheimnis der Zebrafische" ist in der ARD Audiothek, auf der Visite-Website und bei Apple Podcasts zu finden. #COL6 Universitätsklinikum Schleswig-Holstein Universität Lübeck Cardiogenetics DZHK Germany #DGM 1.ard.de/AD_F59_DieFors…

Jetzt online:  Abenteuer Diagnose #59 "Die Forscherin und das Geheimnis der Zebrafische" ist in der ARD Audiothek, auf der Visite-Website und bei  Apple Podcasts zu finden. #COL6 <a href="/UKSH_KI_HL/">Universitätsklinikum Schleswig-Holstein</a> <a href="/UniLuebeck/">Universität Lübeck</a> <a href="/cardiogenetics/">Cardiogenetics</a> <a href="/dzhk_germany/">DZHK Germany</a> #DGM
1.ard.de/AD_F59_DieFors…
Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

More than sad to lose our colleague and friend Prof. Jeanette Erdmann: one of THE German pioneers in cardiogenetics! 🖤 Her unlimited enthusiasm for unravelling the role of genetics in cardiovascular health will live on in so many of us. ❤️‍🩹🧬

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Vaccination against arterial hypertension? 💉 Exciting data on a new therapeutic concept to control cardiovascular risk factors beyond lipids. ❤️ nejm.org/doi/full/10.10…

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Still looking for New Year's resolutions? Time to recap the results of our recent study NEJM on the individual and global impact of 5 modifiable cardiovascular risk factors.🫀🩺🚬🍰 Happy and healthy 2024! UKE Hamburg University Center of Cardiovascular Science (UCCS) nejm.org/do/10.1056/NEJ…

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

🚨Most excited about the results of our industry-independent DEDICATE trial presented by @MoritzSeiffert at #ACC24 and NEJM, impressively demonstrating non-inferior safety of #TAVI versus #SAVR in lower risk patients. ❤️‍🩹DZHK Germany University Center of Cardiovascular Science (UCCS) UKE Hamburg nejm.org/doi/full/10.10…

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Gratulation an @MoritzSeiffert und alle Beteiligten für die erfolgreiche Durchführung dieser wegweisenden Studie, welche komplett industrie-unabhängig durch die DZHK Germany und Deutsche Herzstiftung gefördert wurde. 👏

Deutsche Gesellschaft für Kardiologie (@dgk_org) 's Twitter Profile Photo

Heute ist der erste #BILDHerzgipfel in Berlin. Herzmediziner aus ganz Deutschland kommen zusammen, um über Prävention von Herztod zu sprechen. Mit dabei: Prof. Karl Lauterbach und Experten wie Prof. Holger Thiele und Prof. Stefan Blankenberg. Details: 👉axelspringer.com/de/ax-press-re…

Heute ist der erste #BILDHerzgipfel in Berlin. Herzmediziner aus ganz Deutschland kommen zusammen, um über Prävention von Herztod zu sprechen. Mit dabei:  <a href="/Karl_Lauterbach/">Prof. Karl Lauterbach</a>  und Experten wie Prof. <a href="/thiele_holger/">Holger Thiele</a> und Prof. Stefan Blankenberg. Details: 👉axelspringer.com/de/ax-press-re…
Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Another great study indicating the clinical utility of high-sensitivity entering the point-of-care troponin test arena. 🚨🚑❤️‍🩹Congrats to Luca Koechlin, @J_Boeddinghaus, Pedro Lopez-Ayala, María Rubini and team! jacc.org/doi/10.1016/j.…

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

🚨 Machine-learning algorithm for the rapid and safe triage of patients with suspected myocardial infarction. New data from Betül Toprak, MD et al from UKE Hamburg. Let‘s personalize patient care in the ED with @ACS_Pathfinder ❤️

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Because we firmly believe that AI can support clinicians in their evidence-based decision making and thereby improve acute patient care... ❤️‍🩹🚑❓ Many thanks to 20 Minuten 🇨🇭for their report on the latest research from UKE Hamburg on our @ACS_Pathfinder . 20min.ch/story/kuenstli…

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Safe rule-out of myocardial infarction possible in less than 10 minutes with @ACS_Pathfinder using ML-approaches. 💚or💔❓ Thanks to BILD for their coverage on our study results presented by Betül Toprak, MD from UKE Hamburg @ESCCongress in London. bild.de/leben-wissen/d…

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

🚨Brand new evidence from our global consortium GCVRC quantifying the lifetime-risk for CVD and death by 5️⃣ cvRF and the benefit associated with their modification, just published in NEJM ❤️‍🩹🌍#ACC25